pyrazines has been researched along with formaldehyde in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo, TC; Ellard, GA; Mitchison, DA | 1 |
| Dorman, DE; Engel, GL; Indelicato, JM | 1 |
| FELDER, E; TIEPOLO, U | 1 |
| Gao, Y; Liang, SD; Mu, SN; Xu, BH; Xu, CS | 1 |
| Bonnefous, C; Chen, X; Hassig, CA; Nguyen, PM; Noble, SA; Payne, JE; Rao, TS; Rix, P; Roppe, J; Rozenkrants, N; Sablad, M; Severance, D; Shiau, AK; Smith, ND; Symons, KT; Walsh, JP; Wang, L; Yazdani, N; Zhang, Y; Zhuang, H | 1 |
| Bunch, RT; Euler, C; Haines, E; He, A; Peden, WM; Sanderson, T; Simic, D; Van Vleet, T | 1 |
| Cai, JC; Li, CY; Li, QQ; Liu, JW; Wang, N; Xiong, YH; Zheng, XF | 1 |
7 other study(ies) available for pyrazines and formaldehyde
| Article | Year |
|---|---|
Reappraisal of the activity of morphazinamide against M. tuberculosis.
Topics: Animals; Female; Formaldehyde; Humans; Hydrolysis; Mice; Mycobacterium tuberculosis; Pyrazinamide; Pyrazines; Time Factors; Tuberculosis, Pulmonary | 1975 |
2-Hydroxy-3-aryl-6-methylpyrazines-fluorophores formed from the reaction of formaldehyde with cyclic enamine degradation products common to beta-lactam antibiotics with aryl glycine side chains.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; Chemical Phenomena; Chemistry; Formaldehyde; Glycine; Hydrolysis; Pyrazines; Spectrometry, Fluorescence | 1981 |
[PYRAZINE CARBOXYLIC ACID AMINOMETHYLAMIDES. 1. ON THE LATENT FORMS OF CHEMOTHERAPEUTICALLY ACTIVE PRINCIPLES].
Topics: Carboxylic Acids; Chemistry, Pharmaceutical; Formaldehyde; Pharmacology; Pyrazinamide; Pyrazines; Research | 1964 |
Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Dose-Response Relationship, Drug; Formaldehyde; Ganglia, Spinal; Hindlimb; Injections, Subcutaneous; Male; Membrane Potentials; Neurons, Afferent; Pain; Purinergic P2 Receptor Agonists; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X | 2004 |
Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
Topics: Administration, Oral; Animals; Cell Line; Constriction, Pathologic; Disease Models, Animal; Drug Discovery; Enzyme Inhibitors; Fluoroquinolones; Formaldehyde; Humans; Inhibitory Concentration 50; Lipopolysaccharides; Mice; Nitric Oxide Synthase Type II; Pain; Protein Multimerization; Protein Structure, Quaternary; Pyrazines; Quinolones; Structure-Activity Relationship; Substrate Specificity | 2009 |
MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459.
Topics: Aminopyridines; Animals; Cytochrome P-450 CYP1A1; Enzyme Induction; Female; Formaldehyde; Gene Expression Profiling; Liver; MicroRNAs; Oligonucleotide Array Sequence Analysis; Paraffin Embedding; Pyrazines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2013 |
[Metabolites of endophytic fungus Nigrospora sphaerica S5 from Myoporum bontioides].
Topics: Alkaloids; Anti-Bacterial Agents; Ascomycota; Escherichia coli; Formaldehyde; Indoles; Lactones; Molecular Structure; Myoporum; Phenols; Pyrazines; Sesquiterpenes | 2022 |